GlobalData senior medical device analyst says the acquisition could see Nevro’s growth outside the US accelerate.

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

A Spanish veterinarian known as Maria VetiCan on social media has shared a detailed video on TikTok showing exactly what you ...

Globus Medical expects the Nevro acquisition to be accretive to its earnings in the second year of operation. Globus Medical expects to report full financial results for 2024 and provide its updated ...

Emma, from Newcastle, New South Wales, was fit, healthy, in love and the doting stepmum to two gorgeous boys when her life was turned upside down.